Sientra, Inc. (SIEN) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K/A	10-K
Revenues:
Non-US	1.6	1.7	0.1
Breast Products				37.0	31.5
miraDry				31.1	5.1
Breast Product							38.1
Other	79.0	53.3	46.3
Total revenues	80.7	55.0	46.4	68.1	36.5	20.7	38.1	44.7
Revenue growth [+]	46.7%	18.6%	-31.9%	86.4%	76.2%	-45.6%	-14.8%	27.2%
Non-US	-3.9%	2419.1%
Breast Products				17.6%
miraDry				515.2%
Cost of goods sold	36.3	23.6	16.4	26.8	14.2	6.9	10.7	11.5
Gross profit	44.3	31.4	30.0	41.3	22.4	13.9	27.5	33.2
Gross margin	54.9%	57.1%	64.7%	60.6%	61.2%	66.8%	72.0%	74.3%
Selling, general and administrative [+]	48.5	37.4	37.9	110.1	65.4	42.6	44.5	34.3
Sales and marketing	48.5	37.4	37.9	67.7	33.9	20.6	25.8	23.6
General and administrative				42.4	31.5	22.0	18.7	10.7
Research and development				10.9	9.8	9.7	7.2	4.7
Other operating expenses	57.7	60.7	49.9
EBITDA [+]	-57.5	-63.3	-56.1	-76.5	-49.9	-37.2	-23.9	-5.5
EBITDA growth	-9.3%	13.0%	-26.7%	53.3%	33.9%	55.6%	334.3%	-69.3%
EBITDA margin	-71.2%	-115.2%	-120.9%	-112.2%	-136.4%	-179.6%	-62.8%	-12.3%
Depreciation	3.2	2.1	0.8	1.0	0.8	0.4	0.3	0.2
EBITA	-60.6	-65.4	-56.9	-77.5	-50.7	-37.6	-24.2	-5.7
EBITA margin	-75.1%	-118.9%	-122.7%	-113.7%	-138.7%	-181.4%	-63.6%	-12.7%
Amortization of intangibles	1.2	1.3	0.9	2.3	2.2	0.8		0.1
EBIT [+]	-61.8	-66.7	-57.8	-79.8	-52.9	-38.4	-24.2	-5.8
EBIT growth	-7.3%	15.4%	-27.6%	50.8%	37.7%	58.4%	319.1%	-68.2%
EBIT margin	-76.6%	-121.3%	-124.6%	-117.1%	-144.7%	-185.3%	-63.6%	-12.9%
Non-recurring items [+]					10.0	1.6	14.3
Asset impairment							14.3
Legal settlement					10.0	1.6
Interest expense, net [+]	0.0	-0.2	-1.4	2.9	1.1	0.0	3.1	2.2
Interest expense	8.3	9.4	4.6	3.4	1.2	0.1	3.1	2.2
Interest income	0.0	0.2	1.4	0.5	0.2	0.1	0.0
Other income (expense), net	7.6	8.9	2.9	0.0	-0.1	0.0	0.4	2.1
Pre-tax income	-62.5	-67.1	-58.1	-82.6	-64.0	-40.1	-41.2	-5.8
Income taxes	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
Tax rate				0.0%	0.0%		0.0%	0.0%
Earnings from continuing ops	-62.5	-67.1	-58.1	-82.6	-64.0	-40.2	-41.2	-5.8
Earnings from discontinued ops	0.0	-22.8	-48.7
Net income	-62.5	-89.9	-106.8	-82.6	-64.0	-40.2	-41.2	-5.8
Net margin	-77.4%	-163.5%	-230.4%	-121.3%	-175.2%	-193.7%	-108.2%	-13.0%

Basic EPS [+]	($1.10)	($1.34)	($1.43)	($3.25)	($3.34)	($2.20)	($2.61)	($2.28)
Growth	-18.0%	-6.5%	-56.1%	-2.7%	51.7%	-15.6%	14.3%	-97.2%
Diluted EPS [+]	($1.10)	($1.34)	($1.43)	($3.25)	($3.34)	($2.20)	($2.61)	($2.28)
Growth	-18.0%	-6.5%	-56.1%	-2.7%	51.7%	-15.6%	14.3%	-97.2%

Shares outstanding (basic) [+]	57.1	50.2	40.7	25.4	19.2	18.2	15.8	2.5
Growth	13.6%	23.6%	60.0%	32.6%	5.1%	15.4%	520.6%	994.7%
Shares outstanding (diluted) [+]	57.1	50.2	40.7	25.4	19.2	18.2	15.8	2.5
Growth	13.6%	23.6%	60.0%	32.6%	5.1%	15.4%	520.6%	994.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.